Spirits and beer tracked with higher acute kidney injury risk in UK Biobank
A large prospective analysis from the UK Biobank has drawn a sharp line between different types of alcohol and later acute kidney injury (AKI). Among 250,791 current alcohol consumers followed for a median 14.0 years, spirits and beer were associated with higher AKI risk, while red wine showed no association and white wine did not reach statistical significance. The pattern was not limited to outcome data alone. Baseline inflammatory markers moved in the same direction, creating a biologically plausible signal that alcohol from spirits and beer may not only reflect heavier drinking patterns, but may also contribute to renal injury through inflammatory pathways.
The study matters because AKI has often been framed as a downstream complication of alcohol-related liver disease. Here, the kidney signal persisted independently of liver disease, shifting attention toward a more direct renal effect. In practical terms, the findings argue against treating alcohol-related kidney risk as a purely hepatic problem. Renal injury can emerge without cirrhosis being the explanatory bridge.
Among the beverage categories examined, spirits carried the strongest association with AKI, with a hazard ratio of 1.40 and a 95% confidence interval of 1.30 to 1.50. Beer was also associated with AKI, with a hazard ratio of 1.24 and a 95% confidence interval of 1.17 to 1.32. Red wine did not show an association, with a hazard ratio of 0.96 and a 95% confidence interval of 0.90 to 1.02, while white wine showed a hazard ratio of 1.06 and a 95% confidence interval of 0.98 to 1.14. Those estimates do not prove causation, but they do separate beverage categories in a way that is difficult to dismiss as random noise.
The inflammatory marker data ran in parallel with the outcome findings.
Neutrophil counts and C-reactive protein rose across tertiles of spirits and beer consumption, with both trends significant at P for trend ≤ 0.001 for spirits and < 0.001 for beer. In contrast, both markers fell across tertiles of red wine and white wine consumption, again with P for trend values below 0.001. Baseline C-reactive protein itself was associated with AKI, with a hazard ratio of 1.41 and a 95% confidence interval of 1.34 to 1.47, while baseline neutrophil count showed an even stronger association, with a hazard ratio of 2.60 and a 95% confidence interval of 2.25 to 3.01. Those associations are consistent with a model in which systemic inflammation is not just a bystander, but part of the pathway linking alcohol exposure to kidney injury.
Inflammation may be the biological bridge between alcohol exposure and renal injury
The mechanistic logic is straightforward even if the epidemiology is complex. Alcohol exposure from spirits and beer may promote oxidative stress, endothelial dysfunction, and immune activation, all of which can increase susceptibility to renal hypoperfusion and tubular injury. When neutrophils and CRP are already elevated, the kidney may be operating in a more primed inflammatory state, less able to tolerate hemodynamic stress or toxic insults. That framework fits both the biomarker gradients and the observed interactions between inflammatory markers and alcohol type.
Interactions existed between CRP and neutrophils and spirits in association with AKI, with both interaction terms significant at P < 0.001. The same pattern appeared for beer, again with P < 0.001. Those interactions are the key mechanistic clue in the analysis. They suggest the renal risk linked to spirits and beer is amplified when inflammatory burden is already high, which supports the idea of a direct effect rather than a simple proxy for liver disease alone.
The absence of a clear AKI association for red wine is clinically interesting, but it should not be overread as a protective guarantee. Beverage type in observational cohorts can reflect a dense cluster of behaviors, including drinking pattern, quantity, diet, and broader cardiometabolic profile. Still, the divergence between spirits and beer on one side and wine on the other is consistent with long-standing hypotheses that non-ethanol components, drinking context, and inflammatory signaling may differ across beverage classes.
What the cohort design allows, and what it cannot settle
UK Biobank provides a strong platform for this question because it is large, prospective, and anchored in long follow-up. Baseline data were collected across 22 assessment centres in the United Kingdom, and the cohort included only current alcohol consumers, allowing the analysis to focus on drink type rather than abstention. Alcohol intake was measured in units per week at baseline, along with CRP and neutrophil count, and incident AKI events were captured over years of follow-up. The study also adjusted for covariables and potential confounders in Cox proportional hazards models, strengthening the internal consistency of the findings.
Even so, observational data have limits that matter at the bedside. Drinking habits can change over time, yet baseline intake is only a snapshot. Residual confounding remains possible, particularly around comorbidity, socioeconomic factors, and patterns of binge or chronic intake that may not be fully captured by units per week. The analysis also cannot prove that spirits or beer cause AKI in a direct toxicologic sense. What it can do is show that the signal survives adjustment, aligns with inflammatory biology, and behaves differently across drink categories.
The most useful clinical reading is restrained but firm. Patients with higher inflammatory burden may not be equally exposed to renal risk from all alcohol types, and spirits and beer appear to sit on the higher-risk side of that divide in this cohort. For clinicians who already counsel about liver disease, blood pressure, and metabolic risk, the kidney should now sit more clearly in the same conversation. Acute kidney injury is not merely a late consequence of alcohol-related liver damage; in this dataset, it tracked with alcohol exposures that also tracked with inflammation and with a pattern of risk that was strongest for spirits and beer.